HCT With PTCy in Higher-risk MDS

NCT06098313 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

113

Enrollment

OTHER

Sponsor class

Conditions

Patients With MDS, Acute Myeloid Leukemia (AML) Evolving From MDS, and Chronic Myelomonocytic Leukemia (CMML)

Interventions

DRUG: Cyclophosphamide

Sponsor

Asan Medical Center